[ad_1]
A commission of FDA experts voted in favor of emergency approval.
A committee of experts from the US FDA recommended emergency approval of the corona vaccine from Mainz-based company Biontech and its US partner Pfizer. The panel voted Thursday in a public meeting for approval in the United States, which could now be decided quickly. The vaccine has already been approved in the UK, Canada and other countries, and the EU is currently under review for emergency approval.
The vote of the expert committee is not binding. But everything speaks for the fact that the Biontech vaccine will soon receive emergency approval. The FDA said Tuesday that it classified the vaccine as safe and effective. On Wednesday, the US Department of Health announced that it would use the Biontech vaccine in hospitals and nursing homes beginning early next week.
The vaccine is already approved in the UK, Canada and other countries. In the EU, the examination for an emergency approval is ongoing.
The body produces antigen on its own.
The Biontech vaccine is based on what is known as mRNA technology. Unlike conventional vaccines, the pathogen or parts of the pathogen are not injected, but rather the genetic blueprint of the pathogen is passed on, so that the body produces the antigen on its own and develops an immune response.
In numerical terms, the United States is the country most affected by the corona pandemic. More than 15 million infections with the new type of coronavirus have already been detected here and more than 289,000 infected people have died. Newly elected President Joe Biden, who will take office on January 20, wants to vaccinate 100 million citizens against Corona in the next 100 days.
(what / red.)
